发明授权
US06274307B1 Immunologically active peptides or polypeptides from the parvovirus B19 失效
来自细小病毒B19的免疫活性肽或多肽

  • 专利标题: Immunologically active peptides or polypeptides from the parvovirus B19
  • 专利标题(中): 来自细小病毒B19的免疫活性肽或多肽
  • 申请号: US08856841
    申请日: 1997-05-15
  • 公开(公告)号: US06274307B1
    公开(公告)日: 2001-08-14
  • 发明人: Erwin SoutschekManfred Motz
  • 申请人: Erwin SoutschekManfred Motz
  • 优先权: DE4003826 19900208; WOPCT/DE91/00106 19910208
  • 主分类号: C12Q170
  • IPC分类号: C12Q170
Immunologically active peptides or polypeptides from the parvovirus B19
摘要:
Immunologically active peptides or polypeptides with a partial amino-acid sequence of the capsid proteins VP1 and VP2 of parvovirus B19 which permit tests to be carried out at low cost, sensitively and specifically for the determination of antibodies against human parvovirus B19 are made available. Short peptide sequences which, employed as antigen, serve to identify anti-B19 IgG-positive sera are identified. Furthermore, the production of these peptides using genetic engineering measures is disclosed. Other antigens which are produced by genetic engineering and which can be stably produced in a high yield in E.coli and subsequently purified therefrom are used as additional antigens for IgG detection. Finally, a set of antigens permits tests to be carried out to determine IgM antibodies against the virus. In addition, the components, produced by genetic engineering, of the surface proteins represent substances which can be used for prophylactic immunisation.
信息查询
0/0